ABERNETHY MATT (Chief Financial Officer) reported 1 transaction at NEUROCRINE BIOSCIENCES INC
Review the transaction codes below to understand the nature of each event.
Filed: 3/5/2026ACC: 0001724097-26-000007
Officer· Chief Financial Officer
Since Mar 2026
-2.25K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.25K
Price / share
—
Trade value
—
% of position
5.0%
3/4/2026
45.06K→42.81K
Total
Net shares
−2.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | G · Gift | −2.25K | — | — | 5.0% | 45.06K | 42.81K |
| Total | −2.25K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported